- Home
- PKBK vs INBX Comparison
PKBK vs INBX Comparison
Compare PKBK & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKBK
- INBX
- Stock Information
- Founded
- PKBK 1999
- INBX 2010
- Country
- PKBK United States
- INBX United States
- Employees
- PKBK N/A
- INBX N/A
- Industry
- PKBK Major Banks
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- PKBK Finance
- INBX Health Care
- Exchange
- PKBK Nasdaq
- INBX Nasdaq
- Market Cap
- PKBK 249.7M
- INBX 203.8M
- IPO Year
- PKBK N/A
- INBX 2020
- Fundamental
- Price
- PKBK $23.55
- INBX $14.08
- Analyst Decision
- PKBK
- INBX Hold
- Analyst Count
- PKBK 0
- INBX 1
- Target Price
- PKBK N/A
- INBX N/A
- AVG Volume (30 Days)
- PKBK 24.9K
- INBX 74.9K
- Earning Date
- PKBK 01-22-2025
- INBX 11-14-2024
- Dividend Yield
- PKBK 3.06%
- INBX N/A
- EPS Growth
- PKBK N/A
- INBX N/A
- EPS
- PKBK 2.33
- INBX 119.38
- Revenue
- PKBK $63,152,000.00
- INBX $1,568,000.00
- Revenue This Year
- PKBK N/A
- INBX N/A
- Revenue Next Year
- PKBK N/A
- INBX N/A
- P/E Ratio
- PKBK $10.10
- INBX $0.12
- Revenue Growth
- PKBK N/A
- INBX 19.24
- 52 Week Low
- PKBK $15.24
- INBX $10.80
- 52 Week High
- PKBK $23.55
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- PKBK 70.84
- INBX 38.78
- Support Level
- PKBK $22.25
- INBX $13.64
- Resistance Level
- PKBK $23.10
- INBX $14.63
- Average True Range (ATR)
- PKBK 0.53
- INBX 1.00
- MACD
- PKBK 0.03
- INBX -0.20
- Stochastic Oscillator
- PKBK 100.00
- INBX 35.47
About PKBK Parke Bancorp Inc.
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.